KK
Kanwal Krishan Dogra
About Kanwal Krishan Dogra
Data last updated:
Kanwal Krishan Dogra is a Director at Hesse Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Hesse Pharmaceuticals Private Limited reported revenue of ₹1.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hesse Pharmaceuticals Private Limited U33100PB2020PTC051448 | Director | 21 Jul 2020 | 2020 | ₹1.1 Lakh (FY 2025) | Active |
Board colleagues of Kanwal Krishan Dogra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sameera Dogra | 08802851 | Hesse Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kanwal Krishan Dogra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kanwal Krishan Dogra
Kanwal Krishan Dogra currently holds 1 directorship: Hesse Pharmaceuticals Private Limited (Director, since 21 Jul 2020, revenue ₹1.1 Lakh (FY 2025)).
Kanwal Krishan Dogra was first appointed on 21 Jul 2020 as Director at Hesse Pharmaceuticals Private Limited.
The current boards of Kanwal Krishan Dogra's companies include Sameera Dogra (Hesse Pharmaceuticals Private Limited).